Literature DB >> 35261456

Inducing systemic hyperkalemia for cardiac arrest during cardiopulmonary bypass with patent cardiac circulation.

Altaf Panjwani1, Mitesh J Patel1, Colten Youngblood2, Alessandro Lione1, Justin Schaffer1, Robert Smith1.   

Abstract

In any cardiac patient, efforts should be made to avoid volume overload, especially around the time of surgery. Continuous retrograde Del Nido cardioplegia, a common practice for maintaining cardiac arrest during a procedure when a patient has patent circulation, has the unintended side effect of significantly adding to the net fluid infused into the patient. Systemic hyperkalemia has been induced to reduce the amount of cardioplegia needed to maintain cardiac electromechanical arrest. To supplement knowledge regarding this technique, we report our experiences using systemic hyperkalemia in the context of the use of Del Nido cardioplegia.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Cardioplegia; Del Nido cardioplegia; cardiopulmonary bypass; hyperkalemia; redo cardiovascular surgery

Year:  2021        PMID: 35261456      PMCID: PMC8865256          DOI: 10.1080/08998280.2021.2002790

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  3 in total

1.  Does the Type of Cardioplegic Technique Influence Hemodilution and Transfusion Requirements in Adult Patients Undergoing Cardiac Surgery?

Authors:  Alfred H Stammers; Eric A Tesdahl; Linda B Mongero; Andrew J Stasko; Samuel Weinstein
Journal:  J Extra Corpor Technol       Date:  2017-12

2.  Aortic valve surgery after previous coronary artery bypass grafting with functioning internal mammary artery grafts.

Authors:  John G Byrne; Alexandros N Karavas; Farzan Filsoufi; Tomislav Mihaljevic; Lishan Aklog; David H Adams; Lawrence H Cohn; Sary F Aranki
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

3.  Systemic hyperkalemia for cardiac arrest on CPB with or without cross-clamping.

Authors:  Tharumenthiran Ramanathan; Prem Shekar; Daniel Fitzgerald; Ravi K Ghanta; Sary F Aranki; Lawrence H Cohn; Edward P Chen; Frederick Y Chen
Journal:  J Card Surg       Date:  2008 Nov-Dec       Impact factor: 1.620

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.